Data News > Top gainers in TOP US - Healthcare Companies - MRK, ABBV, JNJ, AMGN, PFE
MRK is trading UP for the last 1 days, and it at trading at $99.39 with volume of 4,561,857 and a one day change of $1.02 (1.04%). Merck & Co., Inc. has a 52-week low of 94.48 and a 52-week high of $134.63. The business's 50-day moving average price is $101.52 and its 200 day moving average price is $115.78. The firm has a market cap of $249 million, a P/E ratio of 144.51, and a beta of 0.41.
UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's therapy to treat a rare lung condition called pulmonary arterial hypertension. The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb (BMY -2.81%) and Merck & Co. (MRK -1.33%) stand out for their combination of above-average dividend yields and proven business models.
For more information on MRK:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
ABBV is trading UP for the last 1 days, and it at trading at $177.71 with volume of 1,671,488 and a one day change of $1.51 (0.86%). AbbVie Inc. has a 52-week low of 146.38 and a 52-week high of $207.32. The business's 50-day moving average price is $185.01 and its 200 day moving average price is $176.93. The firm has a market cap of $310 million, a P/E ratio of 47.84, and a beta of 0.61.
AbbVie (ABBV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
For more information on ABBV:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
JNJ is trading UP for the last 1 days, and it at trading at $144.56 with volume of 3,966,496 and a one day change of $1.22 (0.85%). Johnson & Johnson has a 52-week low of 143.13 and a 52-week high of $168.85. The business's 50-day moving average price is $156.46 and its 200 day moving average price is $156.73. The firm has a market cap of $346 million, a P/E ratio of 22.27, and a beta of 0.52.
For more information on JNJ:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
AMGN is trading UP for the last 1 days, and it at trading at $260.59 with volume of 1,131,897 and a one day change of $1.29 (0.50%). Amgen Inc. has a 52-week low of 257.80 and a 52-week high of $346.85. The business's 50-day moving average price is $301.38 and its 200 day moving average price is $317.04. The firm has a market cap of $142 million, a P/E ratio of 44.24, and a beta of 0.60.
For more information on AMGN:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
PFE is trading UP for the last 1 days, and it at trading at $26.53 with volume of 22,455,622 and a one day change of $0.11 (0.40%). Pfizer Inc. has a 52-week low of 24.48 and a 52-week high of $31.54. The business's 50-day moving average price is $26.79 and its 200 day moving average price is $28.46. The firm has a market cap of $149 million, a P/E ratio of 0.00, and a beta of 0.62.
The small-cap won't receive an expected payout in the first quarter, creating a cash overhang. Sangamo Therapeutics (SGMO) shares cratered more than 50% Tuesday, a day after the biopharma firm announced that Pfizer (PFE) had pulled out of its deal to co-develop a hemophilia drug. On Monday, Sangamo Therapeutics, Inc. SGMO regained the development and commercialization rights to giroctocogene fitelparvovec, an investigational gene therapy product candidate for moderately severe to severe hemophilia A that it has co-developed with and licensed to Pfizer Inc PFE. The pharmaceutical industry can be a tough business. Companies must innovate constantly to stay relevant because patents protecting their proprietary drugs expire. Pharmaceutical giant Pfizer Inc. NYSE: PFE stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down.
For more information on PFE:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Top gainers in TOP US - Healthcare Companies - MRK, ABBV, JNJ, AMGN, PFE
By KlickAnalytics Data Insights | December 31, 2024 04:39PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'TOP US - Healthcare Companies' theme.
Merck & Co., Inc. (MRK)
MRK is trading UP for the last 1 days, and it at trading at $99.39 with volume of 4,561,857 and a one day change of $1.02 (1.04%). Merck & Co., Inc. has a 52-week low of 94.48 and a 52-week high of $134.63. The business's 50-day moving average price is $101.52 and its 200 day moving average price is $115.78. The firm has a market cap of $249 million, a P/E ratio of 144.51, and a beta of 0.41.
Top news headlines for MRK
For more information on MRK:
AbbVie Inc. (ABBV)
ABBV is trading UP for the last 1 days, and it at trading at $177.71 with volume of 1,671,488 and a one day change of $1.51 (0.86%). AbbVie Inc. has a 52-week low of 146.38 and a 52-week high of $207.32. The business's 50-day moving average price is $185.01 and its 200 day moving average price is $176.93. The firm has a market cap of $310 million, a P/E ratio of 47.84, and a beta of 0.61.
Top news headlines for ABBV
For more information on ABBV:
Johnson & Johnson (JNJ)
JNJ is trading UP for the last 1 days, and it at trading at $144.56 with volume of 3,966,496 and a one day change of $1.22 (0.85%). Johnson & Johnson has a 52-week low of 143.13 and a 52-week high of $168.85. The business's 50-day moving average price is $156.46 and its 200 day moving average price is $156.73. The firm has a market cap of $346 million, a P/E ratio of 22.27, and a beta of 0.52.
For more information on JNJ:
Amgen Inc. (AMGN)
AMGN is trading UP for the last 1 days, and it at trading at $260.59 with volume of 1,131,897 and a one day change of $1.29 (0.50%). Amgen Inc. has a 52-week low of 257.80 and a 52-week high of $346.85. The business's 50-day moving average price is $301.38 and its 200 day moving average price is $317.04. The firm has a market cap of $142 million, a P/E ratio of 44.24, and a beta of 0.60.
For more information on AMGN:
Pfizer Inc. (PFE)
PFE is trading UP for the last 1 days, and it at trading at $26.53 with volume of 22,455,622 and a one day change of $0.11 (0.40%). Pfizer Inc. has a 52-week low of 24.48 and a 52-week high of $31.54. The business's 50-day moving average price is $26.79 and its 200 day moving average price is $28.46. The firm has a market cap of $149 million, a P/E ratio of 0.00, and a beta of 0.62.
Top news headlines for PFE
For more information on PFE:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.